Daniel Patrick O'Day Gilead Sciences, Inc. (GILD) insider trading activity

Daniel Patrick O'Day is Chairman & CEO of GILEAD SCIENCES, INC.. Currently has a direct ownership of 630,268 shares of GILD, which is worth approximately $68.9 Million. The most recent transaction as insider was on Jan 24, 2023, when has been sold 215,017 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 630K

25.67% 3M change

29.99% 12M change

Total Value Held $68.9 Million

Daniel Patrick O'Day Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 24 2023	BUY Grant, award, or other acquisition	-	215,017 Added 34.29%	412,053 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$135,649 $87.97 p/Share	1,542 Reduced 0.6%	254,636 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	3,300 Added 1.27%	256,178 Common Stock
Sep 10 2022	SELL Payment of exercise price or tax liability	$99,748 $65.28 p/Share	1,528 Reduced 0.6%	252,878 Common Stock
Sep 10 2022	BUY Exercise of conversion of derivative security	-	3,301 Added 1.28%	254,406 Common Stock
Jun 10 2022	SELL Payment of exercise price or tax liability	$93,479 $60.74 p/Share	1,539 Reduced 0.61%	251,105 Common Stock
Jun 10 2022	BUY Exercise of conversion of derivative security	-	3,300 Added 1.29%	252,644 Common Stock
Mar 10 2022	SELL Payment of exercise price or tax liability	$640,132 $57.92 p/Share	11,052 Reduced 4.24%	249,344 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	-	24,003 Added 8.44%	260,396 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$1,400,744 $60.26 p/Share	23,245 Reduced 8.95%	236,393 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	54,284 Added 17.29%	259,638 Common Stock
Jan 26 2022	SELL Payment of exercise price or tax liability	$2,278,314 $67.34 p/Share	33,833 Reduced 14.14%	205,354 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	146,678 Added 38.01%	239,187 Common Stock
Mar 10 2021	SELL Payment of exercise price or tax liability	$327,411 $63.91 p/Share	5,123 Reduced 3.48%	142,013 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	-	10,800 Added 6.84%	147,136 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$1,537,765 $62.46 p/Share	24,620 Reduced 15.3%	136,336 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	-	54,286 Added 25.22%	160,956 Common Stock
Jan 26 2021	BUY Grant, award, or other acquisition	-	59,100 Added 35.65%	106,670 Common Stock
Mar 01 2020	SELL Payment of exercise price or tax liability	$1,797,949 $69.36 p/Share	25,922 Reduced 35.27%	47,570 Common Stock
Mar 01 2020	BUY Exercise of conversion of derivative security	-	54,288 Added 42.49%	73,492 Common Stock

DPO

Daniel Patrick O'Day

Chairman & CEO

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account